Brief Interest in agilon health, inc. (NYSE: AGL) grows 5.8%

0

agilon health, inc. (NYSE:AGL – Get Rating) was the target of strong short-term interest growth during the month of October. As of October 31, there was short interest totaling 24,030,000 shares, a growth of 5.8% from the total of 22,720,000 shares as of October 15. Currently, 11.5% of the stock’s shares are sold short. Based on an average daily trading volume of 2,270,000 shares, the day-to-cover ratio is currently 10.6 days.

Changes to analyst ratings

Several brokerages have recently weighed in on AGL. TheStreet downgraded shares of agilon health from a “c-” rating to a “d+” rating in a Thursday, August 18 research note. Goldman Sachs Group cut its price target on agilon health shares from $38.00 to $34.00 and set a “buy” rating for the company in a research note on Tuesday. Wells Fargo & Company cut its price target on agilon health shares from $28.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday. Royal Bank of Canada assumed coverage for Agilon Health in a Wednesday, September 14 report. They issued an “outperform” rating and a price target of $33.00 for the company. Finally, SVB Leerink lowered its price target on agilon health from $33.00 to $30.00 and set an “outperform” rating for the company in a Friday, November 4 report. One research analyst gave the stock a hold rating and seven gave the stock a buy rating. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $29.14.

Insider Trading at Agilon Health

In other news, insider Benjamin Shaker sold 29,548 shares of agilon health stock in a trade on Thursday, October 20. The stock was sold at an average price of $20.37, for a total transaction of $601,892.76. Following the completion of the transaction, the insider now owns 25,625 shares of the company, valued at approximately $521,981.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Separately, insider Benjamin Kornitzer sold 8,094 shares of the company in a trade dated Friday, September 9. The shares were sold at an average price of $23.08, for a total value of $186,809.52. Following the completion of the transaction, the insider now owns 10,853 shares of the company, valued at approximately $250,487.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available on the SEC’s website. Additionally, insider Benjamin Shaker sold 29,548 shares of the company in a trade dated Thursday, October 20. The shares were sold at an average price of $20.37, for a total transaction of $601,892.76. Following the completion of the transaction, the insider now directly owns 25,625 shares of the company, valued at approximately $521,981.25. The disclosure of this sale can be found here. Insiders sold 72,716 shares of the company valued at $1,578,866 in the past 90 days. 3.30% of the shares are currently held by insiders.

Hedge funds weigh on Agilon’s health

Institutional investors and hedge funds have recently been buying and selling stocks. Level Financial Advisors Inc. bought a new position in Agilon Health in Q2 worth approximately $25,000. First Horizon Advisors Inc. increased its stake in agilon health by 772.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company worth $31,000 after acquiring an additional 1,074 shares during the period. IFP Advisors Inc increased its stake in agilon health by 236.3% in the 3rd quarter. IFP Advisors Inc now owns 1,231 shares of the company worth $38,000 after acquiring an additional 865 shares during the period. Van ECK Associates Corp bought a new position in Agilon Health in Q3 for a value of around $45,000. Finally, Lazard Asset Management LLC acquired a new position in agilon health stock in Q1 worth approximately $69,000.

Agilon Health Performance Award

NYSE AGL fell $0.50 on Wednesday, hitting $18.29. The company had a trading volume of 19,345 shares, compared to an average volume of 1,879,255. Agilon Health has a 1-year low of $14.36 and a 1-year high of $28.36. The company has a 50-day moving average of $21.58 and a 200-day moving average of $21.71. The company has a quick ratio of 2.48, a current ratio of 2.48 and a leverage ratio of 0.04.

Agilon Health Company Profile

(Get an assessment)

agilon health, inc. provides health services to seniors through primary care physicians in communities across the United States. As of December 31, 2021, it served approximately 238,000 senior members, including 186,300 members receiving Medicare Advantage and 51,700 receiving Medicare Fee-for-Service.

Featured Articles

This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider agilon health, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and agilon health wasn’t on the list.

Although agilon health currently has a “moderate buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

Share.

Comments are closed.